Beta Bionic, Inc. (BBNX)

Beta Bionic Statistics

Total Valuation

Market Cap	n/a
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	3.82
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	14.37

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	$182,247
Profits Per Employee	-$190,708
Employee Count	291
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Beta Bionic had revenue of $53.03 million and -$55.50 million in losses.

Revenue	53.03M
Gross Profit	29.26M
Operating Income	-40.58M
Pretax Income	-55.50M
Net Income	-55.50M
EBITDA	-57.35M
EBIT	-59.65M
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has $60.90 million in cash and $7.30 million in debt, giving a net cash position of $53.60 million.

Cash & Cash Equivalents	60.90M
Total Debt	7.30M
Net Cash	53.60M
Net Cash Per Share	n/a
Equity (Book Value)	-228.85M
Book Value Per Share	n/a
Working Capital	64.68M

Cash Flow

In the last 12 months, operating cash flow was -$40.34 million and capital expenditures -$3.15 million, giving a free cash flow of -$43.49 million.

Operating Cash Flow	-40.34M
Capital Expenditures	-3.15M
Free Cash Flow	-43.49M
FCF Per Share	n/a

Margins

Gross margin is 55.17%, with operating and profit margins of -76.52% and -104.64%.

Gross Margin	55.17%
Operating Margin	-76.52%
Pretax Margin	-104.64%
Profit Margin	-104.64%
EBITDA Margin	-108.14%
EBIT Margin	-112.47%
FCF Margin	-82.00%

Dividends & Yields

Beta Bionic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a